id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S10366 R38057 |
Zhu - Azoles (Local routes), 2020 | Central Nervous System malformations | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Route of exposure Azoles: Local (NOS) | 1.03 [0.88;1.20] C | 162/82,090 3,603/1,875,257 | 3,765 | 82,090 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4170 R9630 |
Rotem - Clotrimazole (Vaginal), 2018 | Central nervous system (neural tube defects included) | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Route of exposure Azoles: Vaginal | 1.11 [0.69;1.78] | 18/1,993 789/95,781 | 807 | 1,993 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 1.04 [0.89;1.20] | 4,572 | 84,083 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Local routes; 2: Vaginal;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded